Respirology
Representatives from five Asian countries shared local experiences and current protocols for pharmacotherapy in treating patients with COVID-19 at a recent Asian Young Pharmacists' Group (AYPG) webinar.
Treatment with the DPP 1* inhibitor brensocatib prolonged time to exacerbation and reduced exacerbation rates in patients with non-cystic fibrosis bronchiectasis, according to the phase II WILLOW** study presented at ERS 2020.
Representatives from five Asian countries shared local experiences and current protocols for pharmacotherapy in treating patients with COVID-19 at a recent Asian Young Pharmacists' Group (AYPG) webinar.
Treatment with the DPP 1* inhibitor brensocatib prolonged time to exacerbation and reduced exacerbation rates in patients with non-cystic fibrosis bronchiectasis, according to the phase II WILLOW** study presented at ERS 2020.
Malaysia
Sign In
Change Password
Points
Sign Out
